Genertec Universal Medical reports unchanged share capital and compliant public float for May 2026

Bulletin Express06-04

Genertec Universal Medical Group Company Limited submitted its monthly return to Hong Kong Exchanges and Clearing on 4 June 2026, covering movements in securities for the month ended 31 May 2026.

The total issued share capital remained unchanged at 2.01 billion ordinary shares, with zero treasury shares held or cancelled during the period. No new shares were issued and no shares were repurchased.

The company confirmed that it satisfied the Main Board public-float requirement, maintaining at least 25% of its issued shares in public hands as at 31 May 2026.

Under the share option scheme approved on 31 December 2019, no options were outstanding or exercised during the month. The scheme still allows the potential issue of up to 155.57 million shares, representing approximately 7.72% of the current issued share capital.

The filing states there were no warrants, convertible securities, or other agreements that would affect the share capital, and all regulatory confirmations were signed by Executive Director Chen Shisu.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1187693819?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-04 16:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1187693819","market":"us","top_or_hot":-1,"title":"Genertec Universal Medical reports unchanged share capital and compliant public float for May 2026","media":"Bulletin Express","content":"<p>Genertec Universal Medical Group Company Limited submitted its monthly return to Hong Kong Exchanges and Clearing on 4 June 2026, covering movements in securities for the month ended 31 May 2026.</p>\n<p>The total issued share capital remained unchanged at 2.01 billion ordinary shares, with zero treasury shares held or cancelled during the period. No new shares were issued and no shares were repurchased.</p>\n<p>The company confirmed that it satisfied the Main Board public-float requirement, maintaining at least 25% of its issued shares in public hands as at 31 May 2026.</p>\n<p>Under the share option scheme approved on 31 December 2019, no options were outstanding or exercised during the month. The scheme still allows the potential issue of up to 155.57 million shares, representing approximately 7.72% of the current issued share capital.</p>\n<p>The filing states there were no warrants, convertible securities, or other agreements that would affect the share capital, and all regulatory confirmations were signed by Executive Director Chen Shisu.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Genertec Universal Medical reports unchanged share capital and compliant public float for May 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenertec Universal Medical reports unchanged share capital and compliant public float for May 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-04 16:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Genertec Universal Medical Group Company Limited submitted its monthly return to Hong Kong Exchanges and Clearing on 4 June 2026, covering movements in securities for the month ended 31 May 2026.</p>\n<p>The total issued share capital remained unchanged at 2.01 billion ordinary shares, with zero treasury shares held or cancelled during the period. No new shares were issued and no shares were repurchased.</p>\n<p>The company confirmed that it satisfied the Main Board public-float requirement, maintaining at least 25% of its issued shares in public hands as at 31 May 2026.</p>\n<p>Under the share option scheme approved on 31 December 2019, no options were outstanding or exercised during the month. The scheme still allows the potential issue of up to 155.57 million shares, representing approximately 7.72% of the current issued share capital.</p>\n<p>The filing states there were no warrants, convertible securities, or other agreements that would affect the share capital, and all regulatory confirmations were signed by Executive Director Chen Shisu.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02666","symbol_name":"环球医疗","start_time":0,"source_url":"","article_id":"1187693819","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1187693819","pubTimestamp":1780562915,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Genertec Universal Medical Group Company Limited submitted its monthly return to Hong Kong Exchanges and Clearing on 4 June 2026, covering movements in securities for the month ended 31 May 2026. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02666":"环球医疗"},"translate_title":"Genertec Universal Medical报告2026年5月股本和合规公众持股量不变","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02666":1},"content_text":"Genertec Universal Medical Group Company Limited submitted its monthly return to Hong Kong Exchanges and Clearing on 4 June 2026, covering movements in securities for the month ended 31 May 2026.\nThe total issued share capital remained unchanged at 2.01 billion ordinary shares, with zero treasury shares held or cancelled during the period. No new shares were issued and no shares were repurchased.\nThe company confirmed that it satisfied the Main Board public-float requirement, maintaining at least 25% of its issued shares in public hands as at 31 May 2026.\nUnder the share option scheme approved on 31 December 2019, no options were outstanding or exercised during the month. The scheme still allows the potential issue of up to 155.57 million shares, representing approximately 7.72% of the current issued share capital.\nThe filing states there were no warrants, convertible securities, or other agreements that would affect the share capital, and all regulatory confirmations were signed by Executive Director Chen Shisu.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1187693819","isCrawlerRequest":true}